Polymorphic form of pridopidine hydrochloride
AssigneeIvax International GmbH
InventorsClas Sonesson, Thomas Pittelkow, Brian Frøstrup, Anne Zimmermann
Life of this patent
Estimating the term…
Abstract
This invention relates to a new crystalline form of Pridopidine, a drug substance currently in development for the treatment of Huntington's disease. More specifically the invention provides polymorphic Form II of the Pridopidine hydrochloride salt, a process for the preparation of this polymorphic form, pharmaceutical compositions comprising polymorphic Form II, and methods of uses of this polymorphic form.
Claims5
4-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine hydrochloride salt in a crystalline form, wherein the crystalline form is anhydrous crystalline Form II characterized by an X-ray powder diffraction pattern with reflections corresponding to the d-spacing values 6.1 and 4.9, and 8.9 and 4.1.
Dependencies are inferred from the claim text.